iifl-logo

Aspira Pathlab & Diagnostics Ltd Share Price

59.22
(-4.94%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open59.19
  • Day's High64
  • 52 Wk High106.78
  • Prev. Close62.3
  • Day's Low59.19
  • 52 Wk Low 25
  • Turnover (lac)0.34
  • P/E75.98
  • Face Value10
  • Book Value10.8
  • EPS0.82
  • Mkt. Cap (Cr.)60.96
  • Div. Yield0
View All Historical Data
No Records Found

Aspira Pathlab & Diagnostics Ltd KEY RATIOS

Sector

Healthcare

Open

59.19

Prev. Close

62.3

Turnover(Lac.)

0.34

Day's High

64

Day's Low

59.19

52 Week's High

106.78

52 Week's Low

25

Book Value

10.8

Face Value

10

Mkt Cap (₹ Cr.)

60.96

P/E

75.98

EPS

0.82

Divi. Yield

0

Aspira Pathlab & Diagnostics Ltd Corporate Action

27 Aug 2024

12:00 AM

BookCloser

arrow

27 Aug 2024

12:00 AM

AGM

Announcement Date: 27 Aug, 2024

arrow

31 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Aspira Pathlab & Diagnostics Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Aspira Pathlab & Diagnostics Ltd SHAREHOLDING SNAPSHOT

09 May, 2025|09:39 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 18.39%

Foreign: 0.00%

Indian: 18.39%

Non-Promoter- 81.60%

Institutions: 0.00%

Non-Institutions: 81.60%

Custodian: 0.00%

Share Price

Aspira Pathlab & Diagnostics Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

10.29

10.29

10.29

10.29

Preference Capital

6.01

5.89

5.79

5.7

Reserves

-5.08

-2.47

-2.43

-6.91

Net Worth

11.22

13.71

13.65

9.08

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

15.2

8.41

4.35

0.75

yoy growth (%)

80.66

93.13

474.3

0

Raw materials

-2.63

-1.98

-1.3

-0.14

As % of sales

17.32

23.61

29.87

18.73

Employee costs

-4.02

-4.94

-3.42

-1.61

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

1.38

-4.21

-5.58

-2.72

Depreciation

-1.44

-1.66

-1.12

-0.19

Tax paid

0

-0.02

0

0

Working capital

0.85

0.84

-1.33

-3.37

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

80.66

93.13

474.3

0

Op profit growth

-292.22

-52.81

50.34

979.16

EBIT growth

-171.01

-33.01

93.64

-3,067.65

Net profit growth

-132.56

-24.03

104.87

-10,028.19

View Ratios
Particulars (Rupees in Crores.)Mar-2024

Gross Sales

13.2

Excise Duty

0

Net Sales

13.2

Other Operating Income

0

Other Income

0.42

Aspira Pathlab & Diagnostics Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Max Healthcare Institute Ltd

MAXHEALTH

1,126.95

134.161,09,555.55138.240.13697.481.72

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,718.8

80.3996,606.04341.60.242,054.8569.62

Fortis Healthcare Ltd

FORTIS

664.8

248.9950,189.6239.560.15366.87120.23

Narayana Hrudayalaya Ltd

NH

1,779.45

84.7436,364.9879.220.22865.0495.32

Global Health Ltd

MEDANTA

1,171

80.1531,451.5899.310624.4113.49

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Aspira Pathlab & Diagnostics Ltd

Management

Register Office

Registrar Office

Managing Director & CEO

Pankaj Jashwant Shah

Independent Director

Mangala Radha Krishnan Prabhu

Chairman & Independent Directo

Haseeb Drabu

Executive Director

Nikunj Mange

Independent Director

Manas Mengar

Company Sec. & Compli. Officer

Krupali Shah

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of Ankur Pathology Laboratory. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targetin
Read More

Company FAQs

What is the Aspira Pathlab & Diagnostics Ltd share price today?

The Aspira Pathlab & Diagnostics Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹59.22 today.

What is the Market Cap of Aspira Pathlab & Diagnostics Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aspira Pathlab & Diagnostics Ltd is ₹60.96 Cr. as of 09 May ‘25

What is the PE and PB ratio of Aspira Pathlab & Diagnostics Ltd?

The PE and PB ratios of Aspira Pathlab & Diagnostics Ltd is 75.98 and 5.77 as of 09 May ‘25

What is the 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd?

The 52-week high/low is the highest and lowest price at which a Aspira Pathlab & Diagnostics Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Aspira Pathlab & Diagnostics Ltd is ₹25 and ₹106.78 as of 09 May ‘25

What is the CAGR of Aspira Pathlab & Diagnostics Ltd?

Aspira Pathlab & Diagnostics Ltd's CAGR for 5 Years at 11.29%, 3 Years at 5.54%, 1 Year at 94.08%, 6 Month at 4.15%, 3 Month at -7.43% and 1 Month at -10.24%.

What is the shareholding pattern of Aspira Pathlab & Diagnostics Ltd?

The shareholding pattern of Aspira Pathlab & Diagnostics Ltd is as follows:
Promoters - 18.39 %
Institutions - 0.00 %
Public - 81.61 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.